Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A nanoliposomal drug delivery system that encapsulates BMEDA-chelated radioactive isotopes (primarily Rhenium-186 or Rhenium-188) within lipid nanoparticles measuring approximately 100 nanometers in diameter. The system functions as both a diagnostic and therapeutic agent (theragnostic).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BMEDA-chelated radioisotope-encapsulated nanoliposome.